Here the authors use genetic models to show that podocyte FGF4 is protective of diabetic kidney disease progression, and that treatment with recombinant FGF4 reduced renal injury and fibrosis in diabetic mouse models. The gene discussed is FGF4; the disease is diabetic kidney disease.